Benefits of apixaban among venous thromboembolism patients with active cancer
Benefits of apixaban among venous thromboembolism patients with active cancer
Inotuzumab ozogamicin and chemotherapy with or without blinatumomab in Philadelphia chromosone-negative ALL
Dasatinib vs imatinib for paediatric Ph ALL
Study of quadruple combination for induction resistant myeloma reveals novel immune checkpoints
KRd vs KTd followed by carfilzomib maintenance in newly diagnosed MM
Updates on REGN1979 in R/R B-cell non-Hodgkins lymphoma
Eligibility criteria in acute myeloid leukaemia clinical trials
Moxetumomab pasudotox-tdfk in heavily retreated r/r hairy cell leukaemia
Azacitidine plus nivolumab in older adults with AML or MDS
Venetoclax chemo combo active and well-tolerated in children with r/r AML
Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause in breast cancer survivors
Cancer Survivorship - Special Issue